{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1727, "items": [{"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:53:56Z", "timestamp": 1574456036169}, "reference-count": 35, "publisher": "Springer Science and Business Media LLC", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Invest New Drugs"], "published-print": {"date-parts": [[2013, 2]]}, "DOI": "10.1007/s10637-012-9801-2", "type": "journal-article", "created": {"date-parts": [[2012, 2, 27]], "date-time": "2012-02-27T05:25:25Z", "timestamp": 1330320325000}, "page": "77-84", "source": "Crossref", "is-referenced-by-count": 42, "title": ["Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors"], "prefix": "10.1007", "volume": "31", "author": [{"given": "Christina M.", "family": "Annunziata", "sequence": "first", "affiliation": []}, {"given": "Elise C.", "family": "Kohn", "sequence": "additional", "affiliation": []}, {"given": "Patricia", "family": "LoRusso", "sequence": "additional", "affiliation": []}, {"given": "Nicole D.", "family": "Houston", "sequence": "additional", "affiliation": []}, {"given": "Robert L.", "family": "Coleman", "sequence": "additional", "affiliation": []}, {"given": "Manuela", "family": "Buzoianu", "sequence": "additional", "affiliation": []}, {"given": "Gabriel", "family": "Robbie", "sequence": "additional", "affiliation": []}, {"given": "Robert", "family": "Lechleider", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 2, 28]]}, "reference": [{"key": "9801_CR1", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/S0002-9440(10)63899-0", "volume": "162", "author": "J Walker-Daniels", "year": "2003", "unstructured": "Walker-Daniels J, Hess AR, Hendrix MJ, Kinch MS (2003) Differential regulation of EphA2 in normal and malignant cells. Am J Pathol 162:1037\u20131042", "journal-title": "Am J Pathol"}, {"key": "9801_CR2", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1002/path.1937", "volume": "208", "author": "J Zhang", "year": "2006", "unstructured": "Zhang J, Hughes S (2006) Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 208:453\u2013461", "journal-title": "J Pathol"}, {"key": "9801_CR3", "doi-asserted-by": "crossref", "first-page": "6316", "DOI": "10.1128/MCB.10.12.6316", "volume": "10", "author": "RA Lindberg", "year": "1990", "unstructured": "Lindberg RA, Hunter T (1990) cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases. Mol Cell Biol 10:6316\u20136324", "journal-title": "Mol Cell Biol"}, {"key": "9801_CR4", "first-page": "613", "volume": "9", "author": "MS Kinch", "year": "2003", "unstructured": "Kinch MS, Moore MB, Harpole DH Jr (2003) Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 9:613\u2013618", "journal-title": "Clin Cancer Res"}, {"key": "9801_CR5", "first-page": "605", "volume": "11", "author": "T Saito", "year": "2004", "unstructured": "Saito T, Masuda N, Miyazaki T, Kanoh K, Suzuki H, Shimura T, Asao T, Kuwano H (2004) Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol Rep 11:605\u2013611", "journal-title": "Oncol Rep"}, {"key": "9801_CR6", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.2174/1568009053765780", "volume": "5", "author": "RC Ireton", "year": "2005", "unstructured": "Ireton RC, Chen J (2005) EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Curr Cancer Drug Targets 5:149\u2013157", "journal-title": "Curr Cancer Drug Targets"}, {"key": "9801_CR7", "doi-asserted-by": "crossref", "first-page": "1193", "DOI": "10.1093/jnci/djp231", "volume": "101", "author": "JW Lee", "year": "2009", "unstructured": "Lee JW, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK (2009) EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst 101:1193\u20131205", "journal-title": "J Natl Cancer Inst"}, {"key": "9801_CR8", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1158/1541-7786.MCR-05-0056", "volume": "3", "author": "J Wykosky", "year": "2005", "unstructured": "Wykosky J, Gibo DM, Stanton C, Debinski W (2005) EphA2 as a novel molecular marker and target in glioblastoma multiforme. Mol Cancer Res 3:541\u2013551", "journal-title": "Mol Cancer Res"}, {"key": "9801_CR9", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1158/1078-0432.CCR-05-1505", "volume": "12", "author": "S Abraham", "year": "2006", "unstructured": "Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI (2006) Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res 12:353\u2013360", "journal-title": "Clin Cancer Res"}, {"key": "9801_CR10", "doi-asserted-by": "crossref", "first-page": "642", "DOI": "10.1016/j.yexcr.2005.10.028", "volume": "312", "author": "M Heroult", "year": "2006", "unstructured": "Heroult M, Schaffner F, Augustin HG (2006) Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312:642\u2013650", "journal-title": "Exp Cell Res"}, {"key": "9801_CR11", "doi-asserted-by": "crossref", "first-page": "9029", "DOI": "10.1200/jco.2008.26.15_suppl.9029", "volume": "26", "author": "P Hwu", "year": "2008", "unstructured": "Hwu P, Sznol M, Kluger H, Rink L, Kim KB, Papadopoulos NE, Sanders D, Boasberg P, Ooi CE, Hamid O (2008) A phase I/II study of CR011-vcMMAE, an antibody toxin conjugate drug, in patients with unresectable stage III/IV melanoma. J Clin Oncol 26:9029 (abstr)", "journal-title": "J Clin Oncol"}, {"key": "9801_CR12", "doi-asserted-by": "crossref", "first-page": "1110", "DOI": "10.1016/j.oraloncology.2008.01.018", "volume": "44", "author": "Z Shao", "year": "2008", "unstructured": "Shao Z, Zhang WF, Chen XM, Shang ZJ (2008) Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol 44:1110\u20131117", "journal-title": "Oral Oncol"}, {"key": "9801_CR13", "first-page": "151", "volume": "19", "author": "LF Wang", "year": "2008", "unstructured": "Wang LF, Fokas E, Bieker M, Rose F, Rexin P, Zhu Y, Pagenstecher A, Engenhart-Cabillic R, An HX (2008) Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19:151\u2013156", "journal-title": "Oncol Rep"}, {"key": "9801_CR14", "doi-asserted-by": "crossref", "first-page": "2410", "DOI": "10.1007/s10620-008-0649-4", "volume": "54", "author": "WJ Yuan", "year": "2009", "unstructured": "Yuan WJ, Ge J, Chen ZK, Wu SB, Shen H, Yang P, Hu B, Zhang GW, Chen ZH (2009) Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients. Dig Dis Sci 54:2410\u20132417", "journal-title": "Dig Dis Sci"}, {"key": "9801_CR15", "doi-asserted-by": "crossref", "first-page": "2562", "DOI": "10.1158/1078-0432.CCR-10-0017", "volume": "16", "author": "JW Lee", "year": "2010", "unstructured": "Lee JW, Stone RL, Lee SJ, Nam EJ, Roh JW, Nick AM, Han HD, Shahzad MM, Kim HS, Mangala LS, Jennings NB, Mao S, Gooya J, Jackson D, Coleman RL, Sood AK (2010) EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res 16:2562\u20132570", "journal-title": "Clin Cancer Res"}, {"key": "9801_CR16", "doi-asserted-by": "crossref", "first-page": "2684", "DOI": "10.1002/cncr.24335", "volume": "115", "author": "AA Kamat", "year": "2009", "unstructured": "Kamat AA, Coffey D, Merritt WM, Nugent E, Urbauer D, Lin YG, Edwards C, Broaddus R, Coleman RL, Sood AK (2009) EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer. Cancer 115:2684\u20132692", "journal-title": "Cancer"}, {"key": "9801_CR17", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1002/ijc.10860", "volume": "103", "author": "T Miyazaki", "year": "2003", "unstructured": "Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H (2003) EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 103:657\u2013663", "journal-title": "Int J Cancer"}, {"key": "9801_CR18", "doi-asserted-by": "crossref", "first-page": "5145", "DOI": "10.1158/1078-0432.CCR-03-0589", "volume": "10", "author": "PH Thaker", "year": "2004", "unstructured": "Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK (2004) EphA2 expression is associated with aggressive features in ovarian carcinoma. Clin Cancer Res 10:5145\u20135150", "journal-title": "Clin Cancer Res"}, {"key": "9801_CR19", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1016/j.ygyno.2004.05.019", "volume": "94", "author": "D Wu", "year": "2004", "unstructured": "Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM (2004) Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma. Gynecol Oncol 94:312\u2013319", "journal-title": "Gynecol Oncol"}, {"key": "9801_CR20", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1016/j.ygyno.2005.06.036", "volume": "99", "author": "L Han", "year": "2005", "unstructured": "Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z (2005) The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas. Gynecol Oncol 99:278\u2013286", "journal-title": "Gynecol Oncol"}, {"key": "9801_CR21", "doi-asserted-by": "crossref", "first-page": "1179", "DOI": "10.1517/14728222.9.6.1179", "volume": "9", "author": "CN Landen", "year": "2005", "unstructured": "Landen CN, Kinch MS, Sood AK (2005) EphA2 as a target for ovarian cancer therapy. Expert Opin Ther Targets 9:1179\u20131187", "journal-title": "Expert Opin Ther Targets"}, {"key": "9801_CR22", "doi-asserted-by": "crossref", "first-page": "9367", "DOI": "10.1158/0008-5472.CAN-08-1933", "volume": "68", "author": "D Jackson", "year": "2008", "unstructured": "Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D, Senter PD, Gao C, Wu H, Kinch M, Coats S, Kiener PA, Tice DA (2008) A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo. Cancer Res 68:9367\u20139374", "journal-title": "Cancer Res"}, {"key": "9801_CR23", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1021/bc0502917", "volume": "17", "author": "SO Doronina", "year": "2006", "unstructured": "Doronina SO, Mendelsohn BA, Bovee TD, Cerveny CG, Alley SC, Meyer DL, Oflazoglu E, Toki BE, Sanderson RJ, Zabinski RF, Wahl AF, Senter PD (2006) Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem 17:114\u2013124", "journal-title": "Bioconjug Chem"}, {"key": "9801_CR24", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.3324/haematol.11480", "volume": "92", "author": "A Younes", "year": "2007", "unstructured": "Younes A, Forero-Torres A, Bartlett N, Leonard JP, Rege B, Kennedy DA, Lorenz J, Sievers EL (2007) A novel antibody-drug conjugate, SGN-35 (anti-CD30-auristatin), induces objective responses in patients with relapsed or refractory Hodgkin lymphoma: preliminary results of a phase I tolerability study. Haematologica 92:64 (abstr P099bis)", "journal-title": "Haematologica"}, {"key": "9801_CR25", "unstructured": "Jackson D (2010) Early stage antibody drug conjugate development: preparations for the clinic. In: http://www.hansonwade.com/events/antibody-drug-conjugates/presentations/Dowdy-Jackson.pdf . Accessed December 13 2010"}, {"key": "9801_CR26", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1093/jnci/92.3.205", "volume": "92", "author": "P Therasse", "year": "2000", "unstructured": "Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216", "journal-title": "J Natl Cancer Inst"}, {"key": "9801_CR27", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1200/JCO.2005.04.0543", "volume": "24", "author": "JJ Lee", "year": "2006", "unstructured": "Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24:1633\u20131642", "journal-title": "J Clin Oncol"}, {"key": "9801_CR28", "first-page": "455", "volume": "6", "author": "SM Swain", "year": "2008", "unstructured": "Swain SM, Arezzo JC (2008) Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management. Clin Adv Hematol Oncol 6:455\u2013467", "journal-title": "Clin Adv Hematol Oncol"}, {"key": "9801_CR29", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1056/NEJMoa1002965", "volume": "363", "author": "A Younes", "year": "2010", "unstructured": "Younes A, Bartlett NL, Leonard JP, Kennedy DA, Lynch CM, Sievers EL, Forero-Torres A (2010) Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 363:1812\u20131821", "journal-title": "N Engl J Med"}, {"key": "9801_CR30", "first-page": "248", "volume": "12", "author": "L Naumovski", "year": "2010", "unstructured": "Naumovski L, Junutula JR (2010) Glembatumumab vedotin, a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer. Curr Opin Mol Ther 12:248\u2013257", "journal-title": "Curr Opin Mol Ther"}, {"key": "9801_CR31", "doi-asserted-by": "crossref", "first-page": "2024", "DOI": "10.1007/s00259-007-0503-5", "volume": "34", "author": "W Cai", "year": "2007", "unstructured": "Cai W, Ebrahimnejad A, Chen K, Cao Q, Li ZB, Tice DA, Chen X (2007) Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur J Nucl Med Mol Imaging 34:2024\u20132036", "journal-title": "Eur J Nucl Med Mol Imaging"}, {"key": "9801_CR32", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1517/14728222.2011.538682", "volume": "15", "author": "M Tandon", "year": "2011", "unstructured": "Tandon M, Vemula SV, Mittal SK (2011) Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets 15:31\u201351", "journal-title": "Expert Opin Ther Targets"}, {"key": "9801_CR33", "doi-asserted-by": "crossref", "first-page": "1074", "DOI": "10.1038/sj.bjc.6604676", "volume": "99", "author": "Q Chang", "year": "2008", "unstructured": "Chang Q, Jorgensen C, Pawson T, Hedley DW (2008) Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. Br J Cancer 99:1074\u20131082", "journal-title": "Br J Cancer"}, {"key": "9801_CR34", "doi-asserted-by": "crossref", "first-page": "6910", "DOI": "10.1158/0008-5472.CAN-05-0530", "volume": "65", "author": "CN Landen Jr", "year": "2005", "unstructured": "Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65:6910\u20136918", "journal-title": "Cancer Res"}, {"key": "9801_CR35", "first-page": "351", "volume": "3", "author": "AM Gobin", "year": "2008", "unstructured": "Gobin AM, Moon JJ, West JL (2008) EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells. Int J Nanomedicine 3:351\u2013358", "journal-title": "Int J Nanomedicine"}], "container-title": ["Investigational New Drugs"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10637-012-9801-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T14:51:00Z", "timestamp": 1497970260000}, "score": 56.93818, "issued": {"date-parts": [[2012, 2, 28]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2013, 2]]}, "issue": "1"}, "alternative-id": ["9801"], "URL": "http://dx.doi.org/10.1007/s10637-012-9801-2", "relation": {"cites": []}, "ISSN": ["0167-6997", "1573-0646"], "issn-type": [{"value": "0167-6997", "type": "print"}, {"value": "1573-0646", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T08:54:49Z", "timestamp": 1575104089281}, "reference-count": 6, "publisher": "Informa UK Limited", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1080/1042819031000077115", "type": "journal-article", "created": {"date-parts": [[2003, 11, 10]], "date-time": "2003-11-10T17:33:23Z", "timestamp": 1068485603000}, "page": "1081-1082", "source": "Crossref", "is-referenced-by-count": 3, "title": ["99mTc-sestaMIBI Scintigraphy in Thalidomide-treated Refractory or Relapsed Multiple Myeloma Patients"], "prefix": "10.1080", "volume": "44", "author": [{"given": "Claudia", "family": "Andretta", "sequence": "first", "affiliation": []}, {"given": "Lucio", "family": "Catalano", "sequence": "additional", "affiliation": []}, {"given": "Leonardo", "family": "Pace", "sequence": "additional", "affiliation": []}, {"given": "Rosa", "family": "Fonti", "sequence": "additional", "affiliation": []}, {"given": "Gaetana", "family": "Annunziata", "sequence": "additional", "affiliation": []}, {"given": "Bruno", "family": "Rotoli", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "p_1", "author": "Barlogie B.", "volume": "38", "first-page": "250", "year": "2001", "journal-title": "Seminars in Hematology", "DOI": "10.1016/S0037-1963(01)90017-4", "doi-asserted-by": "crossref"}, {"key": "p_2", "author": "Fonti R.", "volume": "28", "first-page": "214", "year": "2001", "journal-title": "European Journal of Nuclear Medicine", "DOI": "10.1007/s002590000434", "doi-asserted-by": "crossref"}, {"key": "p_3", "author": "Wakasugi S.", "volume": "23", "first-page": "664", "year": "1998", "journal-title": "Clinical Nuclear Medicine", "DOI": "10.1097/00003072-199810000-00004", "doi-asserted-by": "crossref"}, {"key": "p_4", "author": "Pace L.", "volume": "25", "first-page": "714", "year": "1998", "journal-title": "European Journal of Nuclear Medicine", "DOI": "10.1007/s002590050274", "doi-asserted-by": "crossref"}, {"key": "p_5", "author": "Catalano L.", "volume": "84", "first-page": "119", "year": "1999", "journal-title": "Haematologica"}, {"key": "p_6", "author": "Svaldi M.", "volume": "80", "first-page": "393", "year": "2001", "journal-title": "Annals of Hematology", "DOI": "10.1007/s002770100318", "doi-asserted-by": "crossref"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/1042819031000077115", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T02:06:28Z", "timestamp": 1497578788000}, "score": 25.528442, "issued": {"date-parts": [[2003, 1]]}, "references-count": 6, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[2003, 1]]}, "issue": "6"}, "alternative-id": ["10.1080/1042819031000077115"], "URL": "http://dx.doi.org/10.1080/1042819031000077115", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}], "subject": ["Cancer Research", "Oncology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:21:29Z", "timestamp": 1574691689348}, "reference-count": 78, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 90, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100005010", "name": "Associazione Italiana per la Ricerca sul Cancro", "doi-asserted-by": "publisher", "award": ["15835"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Pathol."], "published-print": {"date-parts": [[2015, 9]]}, "DOI": "10.1002/path.4558", "type": "journal-article", "created": {"date-parts": [[2015, 5, 7]], "date-time": "2015-05-07T14:15:01Z", "timestamp": 1431008101000}, "page": "4-13", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment"], "prefix": "10.1002", "volume": "237", "author": [{"given": "Antonino", "family": "Carbone", "sequence": "first", "affiliation": [{"name": "Department of Pathology, Centro di Riferimento Oncologico Aviano; Istituto Nazionale Tumori; IRCCS, Aviano Italy"}]}, {"given": "Annunziata", "family": "Gloghini", "sequence": "additional", "affiliation": [{"name": "Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS; Istituto Nazionale Tumori; Milano Italy"}]}, {"given": "Luca", "family": "Castagna", "sequence": "additional", "affiliation": [{"name": "Department of Oncology and Haematology, Humanitas Cancer Centre; Humanitas Clinical and Research Centre; Milan Italy"}]}, {"given": "Armando", "family": "Santoro", "sequence": "additional", "affiliation": [{"name": "Department of Oncology and Haematology, Humanitas Cancer Centre; Humanitas Clinical and Research Centre; Milan Italy"}]}, {"given": "Carmelo", "family": "Carlo-Stella", "sequence": "additional", "affiliation": [{"name": "Department of Oncology and Haematology, Humanitas Cancer Centre; Humanitas Clinical and Research Centre; Milan Italy"}, {"name": "Department of Medical Biotechnology and Translational Medicine; University of Milan; Italy"}]}], "member": "311", "published-online": {"date-parts": [[2015, 6, 3]]}, "reference": [{"key": "10.1002/path.4558-BIB0001|path4558-cit-0001", "author": "Stein", "first-page": "326", "year": "2008", "edition": "4", "volume-title": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "10.1002/path.4558-BIB0002|path4558-cit-0002", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1111/j.1365-2796.2008.02031.x", "article-title": "Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence", "volume": "264", "author": "Hjalgrim", "year": "2008", "journal-title": "J Intern Med"}, {"key": "10.1002/path.4558-BIB0003|path4558-cit-0003", "author": "Poppema", "first-page": "323", "year": "2008", "edition": "4", "volume-title": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "10.1002/path.4558-BIB0004|path4558-cit-0004", "first-page": "3108", "article-title": "Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin", "volume": "94", "author": "Foss", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0005|path4558-cit-0005", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1002/path.2711", "article-title": "The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape", "volume": "221", "author": "Aldinucci", "year": "2010", "journal-title": "J Pathol"}, {"key": "10.1002/path.4558-BIB0006|path4558-cit-0006", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/j.semcancer.2013.07.002", "article-title": "The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component", "volume": "24", "author": "Liu", "year": "2014", "journal-title": "Semin Cancer Biol"}, {"key": "10.1002/path.4558-BIB0007|path4558-cit-0007", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1200/JCO.2010.32.8401", "article-title": "Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment", "volume": "29", "author": "Steidl", "year": "2011", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0008|path4558-cit-0008", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1200/JCO.1987.5.1.27", "article-title": "Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy", "volume": "5", "author": "Santoro", "year": "1987", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0009|path4558-cit-0009", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1056/NEJMoa1000067", "article-title": "Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma", "volume": "363", "author": "Engert", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/path.4558-BIB0010|path4558-cit-0010", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1200/JCO.2013.53.1194", "article-title": "Treatment of Hodgkin lymphoma: a 50-year perspective", "volume": "32", "author": "Canellos", "year": "2014", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0011|path4558-cit-0011", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1016/0140-6736(93)92411-L", "article-title": "Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial", "volume": "341", "author": "Linch", "year": "1993", "journal-title": "Lancet"}, {"key": "10.1002/path.4558-BIB0012|path4558-cit-0012", "doi-asserted-by": "crossref", "first-page": "1485", "DOI": "10.1023/A:1008343823292", "article-title": "Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study Group", "volume": "10", "author": "Brice", "year": "1999", "journal-title": "Ann Oncol"}, {"key": "10.1002/path.4558-BIB0013|path4558-cit-0013", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1182/blood.V97.3.616", "article-title": "A two-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model", "volume": "97", "author": "Moskowitz", "year": "2001", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0014|path4558-cit-0014", "doi-asserted-by": "crossref", "first-page": "2065", "DOI": "10.1016/S0140-6736(02)08938-9", "article-title": "Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial", "volume": "359", "author": "Schmitz", "year": "2002", "journal-title": "Lancet"}, {"key": "10.1002/path.4558-BIB0015|path4558-cit-0015", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1111/j.1365-2141.2003.04828.x", "article-title": "Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease", "volume": "124", "author": "Moskowitz", "year": "2004", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0016|path4558-cit-0016", "doi-asserted-by": "crossref", "first-page": "1065", "DOI": "10.1016/j.bbmt.2006.06.006", "article-title": "Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma", "volume": "12", "author": "Majhail", "year": "2006", "journal-title": "Biol Blood Marrow Transpl"}, {"key": "10.1002/path.4558-BIB0017|path4558-cit-0017", "doi-asserted-by": "crossref", "first-page": "1344", "DOI": "10.1002/cncr.23715", "article-title": "High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience", "volume": "113", "author": "Gopal", "year": "2008", "journal-title": "Cancer"}, {"key": "10.1002/path.4558-BIB0018|path4558-cit-0018", "doi-asserted-by": "crossref", "first-page": "1251", "DOI": "10.3109/10428194.2010.486090", "article-title": "Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience", "volume": "51", "author": "Viviani", "year": "2010", "journal-title": "Leukemia Lymphoma"}, {"key": "10.1002/path.4558-BIB0019|path4558-cit-0019", "author": "Younes", "volume": "507-519", "year": "2009", "article-title": "Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma", "journal-title": "Hematology: The Education Program of the American Society of Hematology"}, {"key": "10.1002/path.4558-BIB0020|path4558-cit-0020", "doi-asserted-by": "crossref", "first-page": "2171", "DOI": "10.1200/JCO.2011.39.6416", "article-title": "Brentuximab vedotin and panobinostat: new drugs for Hodgkin's lymphoma\u00a0-\u00a0can they make one of medical oncology's chemotherapy success stories more successful?", "volume": "30", "author": "Canellos", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0021|path4558-cit-0021", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.1111/j.1365-2141.2009.07727.x", "article-title": "Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin's lymphoma", "volume": "146", "author": "Moskowitz", "year": "2009", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0022|path4558-cit-0022", "doi-asserted-by": "crossref", "first-page": "2430", "DOI": "10.1093/annonc/mdt206", "article-title": "Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation", "volume": "24", "author": "Martinez", "year": "2013", "journal-title": "Ann Oncol"}, {"key": "10.1002/path.4558-BIB0023|path4558-cit-0023", "doi-asserted-by": "crossref", "first-page": "2531", "DOI": "10.3109/10428194.2013.798868", "article-title": "Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant", "volume": "54", "author": "Arai", "year": "2013", "journal-title": "Leukemia Lymphoma"}, {"key": "10.1002/path.4558-BIB0024|path4558-cit-0024", "author": "Crump", "volume": "326-333", "year": "2008", "article-title": "Management of Hodgkin lymphoma in relapse after autologous stem cell transplant", "journal-title": "Hematology:The Education Program of the American Society of Hematology"}, {"key": "10.1002/path.4558-BIB0025|path4558-cit-0025", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1038/nrclinonc.2010.189", "article-title": "Beyond chemotherapy: new agents for targeted treatment of lymphoma", "volume": "8", "author": "Younes", "year": "2011", "journal-title": "Nat Rev Clin Oncol"}, {"key": "10.1002/path.4558-BIB0026|path4558-cit-0026", "doi-asserted-by": "crossref", "first-page": "1812", "DOI": "10.1056/NEJMoa1002965", "article-title": "Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas", "volume": "363", "author": "Younes", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/path.4558-BIB0027|path4558-cit-0027", "doi-asserted-by": "crossref", "first-page": "2183", "DOI": "10.1200/JCO.2011.38.0410", "article-title": "Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma", "volume": "30", "author": "Younes", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0028|path4558-cit-0028", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1056/NEJMoa1411087", "article-title": "PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma", "volume": "372", "author": "Ansell", "year": "2015", "journal-title": "N Engl J Med"}, {"key": "10.1002/path.4558-BIB0029|path4558-cit-0029", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1111/bjh.12821", "article-title": "Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi", "volume": "166", "author": "Anastasia", "year": "2014", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0030|path4558-cit-0030", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1200/JCO.2012.45.3308", "article-title": "Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma", "volume": "31", "author": "Moskowitz", "year": "2013", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0031|path4558-cit-0031", "doi-asserted-by": "crossref", "first-page": "3671", "DOI": "10.1182/blood-2009-12-253856", "article-title": "Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability", "volume": "115", "author": "Sarina", "year": "2010", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0032|path4558-cit-0032", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1200/JCO.2007.13.2415", "article-title": "Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation", "volume": "26", "author": "Sureda", "year": "2008", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0033|path4558-cit-0033", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/j.1365-2141.2010.08492.x", "article-title": "Allogeneic transplantation for Hodgkin's lymphoma", "volume": "152", "author": "Corradini", "year": "2011", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0034|path4558-cit-0034", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.3324/haematol.13441", "article-title": "Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome", "volume": "94", "author": "Robinson", "year": "2009", "journal-title": "Haematologica"}, {"key": "10.1002/path.4558-BIB0035|path4558-cit-0035", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1016/j.bbmt.2008.01.008", "article-title": "Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome", "volume": "14", "author": "Armand", "year": "2008", "journal-title": "Biol Blood Marrow Transpl"}, {"key": "10.1002/path.4558-BIB0036|path4558-cit-0036", "doi-asserted-by": "crossref", "first-page": "2316", "DOI": "10.1038/sj.leu.2404822", "article-title": "Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome", "volume": "21", "author": "Corradini", "year": "2007", "journal-title": "Leukemia"}, {"key": "10.1002/path.4558-BIB0037|path4558-cit-0037", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1016/j.bbmt.2011.03.010", "article-title": "Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation", "volume": "17", "author": "Ram", "year": "2011", "journal-title": "Biol Blood Marrow Transpl"}, {"key": "10.1002/path.4558-BIB0038|path4558-cit-0038", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1038/nrc2542", "article-title": "The biology of Hodgkin's lymphoma", "volume": "9", "author": "Kuppers", "year": "2009", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/path.4558-BIB0039|path4558-cit-0039", "doi-asserted-by": "crossref", "first-page": "4237", "DOI": "10.1182/blood-2013-04-499004", "article-title": "The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1", "volume": "122", "author": "Cader", "year": "2013", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0040|path4558-cit-0040", "doi-asserted-by": "crossref", "first-page": "4152", "DOI": "10.1182/blood-2013-11-534123", "article-title": "Activated DDR1 increases RS cell survival", "volume": "122", "author": "Carbone", "year": "2013", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0041|path4558-cit-0041", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1056/NEJMoa0905680", "article-title": "Tumor-associated macrophages and survival in classic Hodgkin's lymphoma", "volume": "362", "author": "Steidl", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/path.4558-BIB0042|path4558-cit-0042", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/j.ccr.2013.01.008", "article-title": "Role of macrophage targeting in the antitumor activity of trabectedin", "volume": "23", "author": "Germano", "year": "2013", "journal-title": "Cancer Cell"}, {"key": "10.1002/path.4558-BIB0043|path4558-cit-0043", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1038/nature09754", "article-title": "MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers", "volume": "471", "author": "Steidl", "year": "2011", "journal-title": "Nature"}, {"key": "10.1002/path.4558-BIB0044|path4558-cit-0044", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1182/blood-2014-11-610436", "article-title": "Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells", "volume": "125", "author": "Reichel", "year": "2015", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0045|path4558-cit-0045", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1111/j.1365-2141.2010.08497.x", "article-title": "IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion", "volume": "152", "author": "Aldinucci", "year": "2011", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0046|path4558-cit-0046", "first-page": "780", "article-title": "Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines", "volume": "85", "author": "Carbone", "year": "1995", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0047|path4558-cit-0047", "first-page": "912", "article-title": "CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease", "volume": "147", "author": "Carbone", "year": "1995", "journal-title": "Am J Pathol"}, {"key": "10.1002/path.4558-BIB0048|path4558-cit-0048", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/j.canlet.2014.03.030", "article-title": "The NF-\u03baB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma", "volume": "349", "author": "Celegato", "year": "2014", "journal-title": "Cancer Lett"}, {"key": "10.1002/path.4558-BIB0049|path4558-cit-0049", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1182/blood-2002-11-3507", "article-title": "MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival", "volume": "102", "author": "Zheng", "year": "2003", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0050|path4558-cit-0050", "doi-asserted-by": "crossref", "first-page": "3439", "DOI": "10.1172/JCI61245", "article-title": "Hodgkin lymphoma", "volume": "122", "author": "Kuppers", "year": "2012", "journal-title": "J Clin Invest"}, {"key": "10.1002/path.4558-BIB0051|path4558-cit-0051", "author": "K\u00fcppers", "first-page": "74", "year": "2007", "volume-title": "Hodgkin Lymphoma"}, {"key": "10.1002/path.4558-BIB0052|path4558-cit-0052", "author": "Pasqualucci", "first-page": "1511", "year": "2014", "edition": "10", "volume-title": "De Vita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology"}, {"key": "10.1002/path.4558-BIB0053|path4558-cit-0053", "doi-asserted-by": "crossref", "first-page": "3530", "DOI": "10.1182/blood-2012-06-439570", "article-title": "Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma", "volume": "120", "author": "Steidl", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0054|path4558-cit-0054", "doi-asserted-by": "crossref", "first-page": "4609", "DOI": "10.1182/blood-2012-05-428896", "article-title": "Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma", "volume": "120", "author": "Tiacci", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0055|path4558-cit-0055", "doi-asserted-by": "crossref", "first-page": "4451", "DOI": "10.1182/blood-2012-09-455873", "article-title": "Lymphoid neoplasia. Laser-capturing the essence of Hodgkin lymphoma", "volume": "120", "author": "Greaves", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0056|path4558-cit-0056", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.1111/bjh.13349", "article-title": "Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach", "volume": "169", "author": "Oki", "year": "2015", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0057|path4558-cit-0057", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1634/theoncologist.2014-0420", "article-title": "Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers", "volume": "20", "author": "Carlo-Stella", "year": "2015", "journal-title": "Oncologist"}, {"key": "10.1002/path.4558-BIB0058|path4558-cit-0058", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.1016/S1470-2045(11)70265-0", "article-title": "Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial", "volume": "12", "author": "Younes", "year": "2011", "journal-title": "Lancet Oncol"}, {"key": "10.1002/path.4558-BIB0059|path4558-cit-0059", "doi-asserted-by": "crossref", "first-page": "2197", "DOI": "10.1200/JCO.2011.38.1350", "article-title": "Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study", "volume": "30", "author": "Younes", "year": "2012", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0060|path4558-cit-0060", "first-page": "320", "article-title": "A phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma", "volume": "85", "author": "Johnston", "year": "2010", "journal-title": "Am J Hematol"}, {"key": "10.1002/path.4558-BIB0061|path4558-cit-0061", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1111/j.1365-2141.2012.09139.x", "article-title": "Phase II study of sorafenib in patients with relapsed or refractory lymphoma", "volume": "158", "author": "Guidetti", "year": "2012", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0062|path4558-cit-0062", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1186/1756-8722-6-46", "article-title": "A phase II study of sorafenib (BAY 43-9006) in recurrent diffuse large B cell lymphoma: an eastern cooperative oncology group study (E1404)", "volume": "6", "author": "Greenwald", "year": "2013", "journal-title": "J Hematol Oncol"}, {"key": "10.1002/path.4558-BIB0063|path4558-cit-0063", "doi-asserted-by": "crossref", "first-page": "5641", "DOI": "10.1158/1078-0432.CCR-14-0770", "article-title": "Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases", "volume": "20", "author": "Guidetti", "year": "2014", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/path.4558-BIB0064|path4558-cit-0064", "doi-asserted-by": "crossref", "first-page": "5119", "DOI": "10.1182/blood-2011-07-362475", "article-title": "A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma", "volume": "118", "author": "Fehniger", "year": "2011", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0065|path4558-cit-0065", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1111/bjh.12120", "article-title": "Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma", "volume": "160", "author": "Corazzelli", "year": "2013", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0066|path4558-cit-0066", "doi-asserted-by": "crossref", "first-page": "1864", "DOI": "10.1016/j.bbmt.2014.06.037", "article-title": "Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma", "volume": "20", "author": "Chen", "year": "2014", "journal-title": "Biol Blood Marrow Transpl"}, {"key": "10.1002/path.4558-BIB0067|path4558-cit-0067", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1182/blood-2011-12-397893", "article-title": "Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation", "volume": "120", "author": "Gopal", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0068|path4558-cit-0068", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.1158/1078-0432.CCR-11-1942", "article-title": "Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy", "volume": "18", "author": "Green", "year": "2012", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/path.4558-BIB0069|path4558-cit-0069", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.1056/NEJMra072067", "article-title": "Epigenetics in cancer", "volume": "358", "author": "Esteller", "year": "2008", "journal-title": "N Engl J Med"}, {"key": "10.1002/path.4558-BIB0070|path4558-cit-0070", "doi-asserted-by": "crossref", "first-page": "5459", "DOI": "10.1200/JCO.2009.22.1291", "article-title": "Histone deacetylase inhibitors in cancer therapy", "volume": "27", "author": "Lane", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "10.1002/path.4558-BIB0071|path4558-cit-0071", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1038/nrd1930", "article-title": "Epigenetic therapy of cancer: past, present and future", "volume": "5", "author": "Yoo", "year": "2006", "journal-title": "Nat Rev Drug Discov"}, {"key": "10.1002/path.4558-BIB0072|path4558-cit-0072", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1111/j.1365-2141.2009.07887.x", "article-title": "Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors", "volume": "147", "author": "Gloghini", "year": "2009", "journal-title": "Br J Haematol"}, {"key": "10.1002/path.4558-BIB0073|path4558-cit-0073", "doi-asserted-by": "crossref", "first-page": "1731", "DOI": "10.1182/blood-2005-09-3731", "article-title": "Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma", "volume": "107", "author": "Younes", "year": "2006", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0074|path4558-cit-0074", "doi-asserted-by": "crossref", "first-page": "4123", "DOI": "10.1182/blood-2012-01-405456", "article-title": "Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma", "volume": "119", "author": "Younes", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0075|path4558-cit-0075", "doi-asserted-by": "crossref", "first-page": "4129", "DOI": "10.1182/blood-2012-01-402792", "article-title": "Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma", "volume": "119", "author": "Kasamon", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/path.4558-BIB0076|path4558-cit-0076", "doi-asserted-by": "crossref", "first-page": "1405", "DOI": "10.3109/10428194.2012.744453", "article-title": "The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)", "volume": "54", "author": "Smith", "year": "2013", "journal-title": "Leukemia Lymphoma"}, {"key": "10.1002/path.4558-BIB0077|path4558-cit-0077", "doi-asserted-by": "crossref", "first-page": "1861", "DOI": "10.1038/leu.2014.81", "article-title": "BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts", "volume": "28", "author": "Locatelli", "year": "2014", "journal-title": "Leukemia"}, {"key": "10.1002/path.4558-BIB0078|path4558-cit-0078", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1186/1756-8722-6-74", "article-title": "The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies", "volume": "6", "author": "Shi", "year": "2013", "journal-title": "J Hematol Oncol"}], "container-title": ["The Journal of Pathology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpath.4558", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 24]], "date-time": "2019-08-24T18:27:43Z", "timestamp": 1566671263000}, "score": 24.747469, "subtitle": ["Primary refractory and early-relapsed Hodgkin's lymphoma"], "issued": {"date-parts": [[2015, 6, 3]]}, "references-count": 78, "journal-issue": {"published-print": {"date-parts": [[2015, 9]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/path.4558", "relation": {"cites": []}, "ISSN": ["0022-3417"], "issn-type": [{"value": "0022-3417", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T19:04:58Z", "timestamp": 1575399898563}, "reference-count": 0, "publisher": "PeerJ", "content-domain": {"domain": []}, "published-print": {"date-parts": [[2019, 2, 7]]}, "DOI": "10.7287/peerj.6309v0.1/reviews/1", "type": "peer-review", "created": {"date-parts": [[2019, 2, 12]], "date-time": "2019-02-12T06:33:04Z", "timestamp": 1549953184000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Peer Review #1 of \"Co-expression of HIF-1\u03b1, MDR1 and LAPTM4B in peripheral blood of solid tumors (v0.1)\""], "prefix": "10.7287", "author": [{"given": "CM", "family": "Della Corte", "sequence": "additional", "affiliation": []}], "member": "4443", "review": {"revision-round": "2", "stage": "pre-publication"}, "deposited": {"date-parts": [[2019, 2, 12]], "date-time": "2019-02-12T06:33:04Z", "timestamp": 1549953184000}, "score": 23.900942, "issued": {"date-parts": [[2019, 2, 7]]}, "references-count": 0, "URL": "http://dx.doi.org/10.7287/peerj.6309v0.1/reviews/1", "relation": {"is-review-of": [{"id-type": "doi", "id": "10.7717/peerj.6309", "asserted-by": "subject"}]}}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T19:22:48Z", "timestamp": 1575400968083}, "reference-count": 0, "publisher": "S. Karger AG", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Dermatology"], "published-print": {"date-parts": [[2013]]}, "DOI": "10.1159/000354263", "type": "journal-article", "created": {"date-parts": [[2013, 11, 20]], "date-time": "2013-11-20T13:12:37Z", "timestamp": 1384953157000}, "page": "305-310", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics"], "prefix": "10.1159", "volume": "227", "author": [{"given": "Maria Sole", "family": "Chimenti", "sequence": "first", "affiliation": []}, {"given": "Miriam", "family": "Teoli", "sequence": "additional", "affiliation": []}, {"given": "Rosita", "family": "Saraceno", "sequence": "additional", "affiliation": []}, {"given": "Annunziata", "family": "Dattola", "sequence": "additional", "affiliation": []}, {"given": "Alessandra", "family": "Ventura", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Chiricozzi", "sequence": "additional", "affiliation": []}, {"given": "Carlo", "family": "Chiaramonte", "sequence": "additional", "affiliation": []}, {"given": "Roberto", "family": "Perricone", "sequence": "additional", "affiliation": []}, {"given": "Sergio", "family": "Chimenti", "sequence": "additional", "affiliation": []}], "member": "127", "container-title": ["Dermatology"], "language": "en", "link": [{"URL": "http://www.karger.com/Article/Pdf/354263", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 10, 25]], "date-time": "2017-10-25T20:08:20Z", "timestamp": 1508962100000}, "score": 22.326075, "issued": {"date-parts": [[2013]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1159/000354263", "ISSN": ["1421-9832", "1018-8665"], "issn-type": [{"value": "1018-8665", "type": "print"}, {"value": "1421-9832", "type": "electronic"}], "subject": ["Dermatology"]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T23:07:49Z", "timestamp": 1575414469382}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2015, 5, 20]]}, "DOI": "10.1200/jco.2015.33.15_suppl.5571", "type": "journal-article", "created": {"date-parts": [[2019, 3, 7]], "date-time": "2019-03-07T22:24:19Z", "timestamp": 1551997459000}, "page": "5571-5571", "source": "Crossref", "is-referenced-by-count": 3, "title": ["A phase 1b, open-label, non-randomized multicenter study of birinapant in combination with conatumumab in subjects with relapsed epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer."], "prefix": "10.1200", "volume": "33", "author": [{"given": "Erika Paige", "family": "Hamilton", "sequence": "first", "affiliation": [{"name": "Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN"}]}, {"given": "Michael J.", "family": "Birrer", "sequence": "additional", "affiliation": [{"name": "Massachusetts General Hospital/Dana Farber Cancer Center, Boston, MA"}]}, {"given": "Brian Anthony", "family": "DiCarlo", "sequence": "additional", "affiliation": [{"name": "Coastal Integrative Cancer Care, San Luis Obispo, CA"}]}, {"given": "Stephanie", "family": "Gaillard", "sequence": "additional", "affiliation": [{"name": "Duke Cancer Inst, Durham, NC"}]}, {"given": "Lainie P.", "family": "Martin", "sequence": "additional", "affiliation": [{"name": "Fox Chase Cancer Ctr, Philadelphia, PA"}]}, {"given": "John J.", "family": "Nemunaitis", "sequence": "additional", "affiliation": [{"name": "Mary Crowley Cancer Research Centers, Dallas, TX"}]}, {"given": "Raymond P.", "family": "Perez", "sequence": "additional", "affiliation": [{"name": "University of Kansas, Fairway, KS"}]}, {"given": "Russell J.", "family": "Schilder", "sequence": "additional", "affiliation": [{"name": "Thomas Jefferson University, Philadelphia, PA"}]}, {"given": "Christina M.", "family": "Annunziata", "sequence": "additional", "affiliation": [{"name": "National Cancer Institute, National Institutes of Health, Bethesda, MD"}]}, {"given": "Colin G.", "family": "Begley", "sequence": "additional", "affiliation": [{"name": "TetraLogic Pharmaceuticals, Westlake Village, CA"}]}, {"given": "Steven Jeffrey", "family": "Hager", "sequence": "additional", "affiliation": [{"name": "California Cancer Associates for Research and Excellence, Fresno, CA"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.5571", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:10:04Z", "timestamp": 1574889004000}, "score": 22.14411, "issued": {"date-parts": [[2015, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2015.33.15_suppl.5571"], "URL": "http://dx.doi.org/10.1200/jco.2015.33.15_suppl.5571", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:54:09Z", "timestamp": 1575183249759}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 9, 1]], "date-time": "1996-09-01T00:00:00Z", "timestamp": 841536000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Physiotherapy"], "published-print": {"date-parts": [[1996, 9]]}, "DOI": "10.1016/s0031-9406(05)66293-1", "type": "journal-article", "created": {"date-parts": [[2005, 10, 24]], "date-time": "2005-10-24T18:12:26Z", "timestamp": 1130177546000}, "page": "547", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Chiropractic Manipulative Skills"], "prefix": "10.1016", "volume": "82", "author": [{"given": "CM", "family": "Norris", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Physiotherapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0031940605662931?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0031940605662931?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 21]], "date-time": "2019-01-21T15:54:53Z", "timestamp": 1548086093000}, "score": 21.810148, "issued": {"date-parts": [[1996, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 9]]}, "issue": "9"}, "alternative-id": ["S0031940605662931"], "URL": "http://dx.doi.org/10.1016/s0031-9406(05)66293-1", "ISSN": ["0031-9406"], "issn-type": [{"value": "0031-9406", "type": "print"}], "subject": ["Physical Therapy, Sports Therapy and Rehabilitation"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T10:18:32Z", "timestamp": 1575454712140}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2019, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs18-p6-21-11", "type": "proceedings-article", "created": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T19:14:04Z", "timestamp": 1557602044000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P6-21-11: Final results from IMPROVE: A randomized, controlled, open-label, cross-over phase IV study to determine the patients' preference for either combined endocrine therapy (exemestane plus everolimus) or immunochemotherapy (capecitabine plus bevacizumab) as first line treatment for advanced HR+/HER2- breast cancer"], "prefix": "10.1158", "author": [{"given": "CM", "family": "Kurbacher", "sequence": "first", "affiliation": []}, {"given": "U", "family": "S\u00f6ling", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Hahn", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Chiabudini", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Maintz", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Rieger", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Falkenstein", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Runkel", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Potthoff", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Decker", "sequence": "additional", "affiliation": []}], "member": "1086", "event": {"name": "Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS18-P6-21-11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T19:40:36Z", "timestamp": 1558208436000}, "score": 20.994026, "issued": {"date-parts": [[2019, 2, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS18-P6-21-11"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs18-p6-21-11"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T11:13:03Z", "timestamp": 1574766783510}, "reference-count": 15, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 7, 1]], "date-time": "2017-07-01T00:00:00Z", "timestamp": 1498867200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Solid-State Electronics"], "published-print": {"date-parts": [[2017, 7]]}, "DOI": "10.1016/j.sse.2017.03.016", "type": "journal-article", "created": {"date-parts": [[2017, 4, 3]], "date-time": "2017-04-03T01:32:04Z", "timestamp": 1491183124000}, "page": "38-44", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Forming operation in Ge-rich Ge x Sb y Te z phase change memories"], "prefix": "10.1016", "volume": "133", "author": [{"given": "Elisabetta", "family": "Palumbo", "sequence": "first", "affiliation": []}, {"given": "Paola", "family": "Zuliani", "sequence": "additional", "affiliation": []}, {"given": "Massimo", "family": "Borghi", "sequence": "additional", "affiliation": []}, {"given": "Roberto", "family": "Annunziata", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Solid-State Electronics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0038110117302575?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0038110117302575?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 3]], "date-time": "2018-09-03T01:51:38Z", "timestamp": 1535939498000}, "score": 20.147026, "issued": {"date-parts": [[2017, 7]]}, "references-count": 15, "alternative-id": ["S0038110117302575"], "URL": "http://dx.doi.org/10.1016/j.sse.2017.03.016", "ISSN": ["0038-1101"], "issn-type": [{"value": "0038-1101", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Forming operation in Ge-rich GexSbyTez phase change memories", "name": "articletitle", "label": "Article Title"}, {"value": "Solid-State Electronics", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.sse.2017.03.016", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:11:23Z", "timestamp": 1574799083984}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs15-p5-09-14", "type": "proceedings-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T08:49:58Z", "timestamp": 1463734198000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P5-09-14: Understanding and attitudes towards cancer clinical research among breast cancer patients compared to the general population: Prospective cross-sectional study"], "prefix": "10.1158", "author": [{"given": "CM", "family": "Kelly", "sequence": "first", "affiliation": []}, {"given": "JA", "family": "McCaffrey", "sequence": "additional", "affiliation": []}, {"given": "CM", "family": "Kelly", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 2, 18]]}, "event": {"name": "Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS15-P5-09-14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:51:49Z", "timestamp": 1558198309000}, "score": 19.909512, "issued": {"date-parts": [[2016, 2, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS15-P5-09-14"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs15-p5-09-14"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T22:45:50Z", "timestamp": 1575326750950}, "reference-count": 0, "publisher": "ZBW - German National Library of Economics", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Economics E-Journal"], "DOI": "10.5018/economics-ejournal.ja.2018-42", "type": "journal-article", "created": {"date-parts": [[2018, 6, 28]], "date-time": "2018-06-28T06:20:40Z", "timestamp": 1530166840000}, "source": "Crossref", "is-referenced-by-count": 3, "title": ["The future of work: how G20 countries can leverage digital-industrial innovations into stronger high-quality jobs growth"], "prefix": "10.5018", "author": [{"given": "Marco", "family": "Annunziata", "sequence": "first", "affiliation": []}, {"given": "Hendrik", "family": "Bourgeois", "sequence": "additional", "affiliation": []}], "member": "2933", "published-online": {"date-parts": [[2018]]}, "container-title": ["Economics: The Open-Access, Open-Assessment E-Journal"], "language": "en", "link": [{"URL": "http://www.economics-ejournal.org/economics/journalarticles/2018-42/version_1/count", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 28]], "date-time": "2018-06-28T06:20:40Z", "timestamp": 1530166840000}, "score": 19.860611, "issued": {"date-parts": [[2018]]}, "references-count": 0, "URL": "http://dx.doi.org/10.5018/economics-ejournal.ja.2018-42", "ISSN": ["1864-6042"], "issn-type": [{"value": "1864-6042", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:43:55Z", "timestamp": 1574307835788}, "reference-count": 6, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Synthetic Communications"], "published-print": {"date-parts": [[1979, 1]]}, "DOI": "10.1080/00397917908066693", "type": "journal-article", "created": {"date-parts": [[2007, 7, 8]], "date-time": "2007-07-08T20:52:08Z", "timestamp": 1183927928000}, "page": "171-178", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Cis, TransStereochemistry and Asymmetric Induction in the Synthesis of Epoxides from Aryl Aldehydes and Phenacyl Halides in a Two-Phase System in the Presence of Chiral Phase-Transfer Catalysts"], "prefix": "10.1080", "volume": "9", "author": [{"given": "R.", "family": "Annunziata", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2006, 12, 5]]}, "reference": [{"key": "CIT0001", "author": "Colonna S.", "first-page": "8", "year": "1978", "journal-title": "J. C. S. Perkin I", "DOI": "10.1039/p19780000008", "doi-asserted-by": "crossref"}, {"key": "CIT0002", "author": "Helder R.", "first-page": "1831", "year": "1976", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/S0040-4039(00)93796-1", "doi-asserted-by": "crossref"}, {"key": "CIT0003", "author": "Wynberg H.", "volume": "30", "first-page": "445", "year": "1976", "journal-title": "Chimia"}, {"key": "CIT0004", "author": "Hummelen J. C.", "first-page": "1089", "year": "1978", "journal-title": "Tetrahedron Lett.", "DOI": "10.1016/S0040-4039(01)85459-9", "doi-asserted-by": "crossref"}, {"key": "CIT0005", "author": "Bodforss S.", "volume": "51", "first-page": "192", "year": "1918", "journal-title": "Chem. Ber.", "DOI": "10.1002/cber.19180510123", "doi-asserted-by": "crossref"}, {"key": "CIT0006", "author": "Ballester M.", "volume": "50", "first-page": "759", "year": "1964", "journal-title": "Anales Real. Soc. Espan Fis. Y Quim."}], "container-title": ["Synthetic Communications"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/00397917908066693", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 17]], "date-time": "2017-06-17T20:33:40Z", "timestamp": 1497731620000}, "score": 19.458652, "issued": {"date-parts": [[1979, 1]]}, "references-count": 6, "journal-issue": {"published-online": {"date-parts": [[2006, 12, 5]]}, "published-print": {"date-parts": [[1979, 1]]}, "issue": "3"}, "alternative-id": ["10.1080/00397917908066693"], "URL": "http://dx.doi.org/10.1080/00397917908066693", "relation": {"cites": []}, "ISSN": ["0039-7911", "1532-2432"], "issn-type": [{"value": "0039-7911", "type": "print"}, {"value": "1532-2432", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T16:15:03Z", "timestamp": 1574784903627}, "reference-count": 1, "publisher": "Wiley", "issue": "32", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 13174, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chemischer Informationsdienst"], "published-print": {"date-parts": [[1979, 8, 7]]}, "DOI": "10.1002/chin.197932117", "type": "journal-article", "created": {"date-parts": [[2016, 4, 13]], "date-time": "2016-04-13T06:55:58Z", "timestamp": 1460530558000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: CIS, TRANS STEREOCHEMISTRY AND ASYMMETRIC INDUCTION IN THE SYNTHESIS OF EPOXIDES FROM ARYL ALDEHYDES AND PHENACYL HALIDES IN A TWO-PHASE SYSTEM IN THE PRESENCE OF CHIRAL PHASE-TRANSFER CATALYSTS"], "prefix": "10.1002", "volume": "10", "author": [{"given": "R.", "family": "ANNUNZIATA", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 4, 12]]}, "reference": [{"key": "10.1002/chin.197932117-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1080/00397917908066693", "article-title": "CIS, TRANS STEREOCHEMISTRY AND ASYMMETRIC INDUCTION IN THE SYNTHESIS OF EPOXIDES FROM ARYL ALDEHYDES AND PHENACYL HALIDES IN A TWO-PHASE SYSTEM IN THE PRESENCE OF CHIRAL PHASE-TRANSFER CATALYSTS", "volume": "9", "author": "ANNUNZIATA", "year": "1979", "journal-title": "Synth. Commun."}], "container-title": ["Chemischer Informationsdienst"], "language": "de", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197932117", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.197932117", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.197932117", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T14:54:10Z", "timestamp": 1533567250000}, "score": 19.458652, "issued": {"date-parts": [[1979, 8, 7]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1979, 8, 7]]}, "issue": "32"}, "URL": "http://dx.doi.org/10.1002/chin.197932117", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0009-2975"], "issn-type": [{"value": "0009-2975", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:59:59Z", "timestamp": 1574539199809}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2013, 4, 15]]}, "DOI": "10.1158/1538-7445.am2013-35", "type": "proceedings-article", "created": {"date-parts": [[2014, 8, 14]], "date-time": "2014-08-14T22:46:55Z", "timestamp": 1408056415000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract 35: Phase I study of dasatinib in combination with bevacizumab in advanced solid tumors (NCT01445509)."], "prefix": "10.1158", "author": [{"given": "Jung-Min", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Christina", "family": "Annunziata", "sequence": "additional", "affiliation": []}, {"given": "Anne M.", "family": "Noonan", "sequence": "additional", "affiliation": []}, {"given": "John L.", "family": "Hays", "sequence": "additional", "affiliation": []}, {"given": "Lori", "family": "Minasian", "sequence": "additional", "affiliation": []}, {"given": "Jo Anne", "family": "Zujewski", "sequence": "additional", "affiliation": []}, {"given": "Helen", "family": "Chen", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "Wright", "sequence": "additional", "affiliation": []}, {"given": "Nicole", "family": "Houston", "sequence": "additional", "affiliation": []}, {"given": "Elise C.", "family": "Kohn", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 18]]}, "event": {"name": "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC"}, "container-title": ["Clinical Trials"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2013-35", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T20:13:32Z", "timestamp": 1558210412000}, "score": 19.27505, "issued": {"date-parts": [[2013, 4, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2013-35"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2013-35"}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:00:36Z", "timestamp": 1576800036857}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "15_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2010, 5, 20]]}, "DOI": "10.1200/jco.2010.28.15_suppl.tps163", "type": "journal-article", "created": {"date-parts": [[2017, 2, 24]], "date-time": "2017-02-24T02:41:10Z", "timestamp": 1487904070000}, "page": "TPS163-TPS163", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Phase I study of dasatinib in combination with bevacizumab in advanced solid tumors."], "prefix": "10.1200", "volume": "28", "author": [{"given": "G.", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "C. M.", "family": "Annunziata", "sequence": "additional", "affiliation": []}, {"given": "G. A.", "family": "Sarosy", "sequence": "additional", "affiliation": []}, {"given": "L. M.", "family": "Minasian", "sequence": "additional", "affiliation": []}, {"given": "S. A.", "family": "Prindiville", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Zujewski", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Otten", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Squires", "sequence": "additional", "affiliation": []}, {"given": "N. D.", "family": "Houston", "sequence": "additional", "affiliation": []}, {"given": "E. C.", "family": "Kohn", "sequence": "additional", "affiliation": []}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2010.28.15_suppl.tps163", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:15:30Z", "timestamp": 1574892930000}, "score": 19.27505, "issued": {"date-parts": [[2010, 5, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 5, 20]]}, "issue": "15_suppl"}, "alternative-id": ["10.1200/jco.2010.28.15_suppl.tps163"], "URL": "http://dx.doi.org/10.1200/jco.2010.28.15_suppl.tps163", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:16:05Z", "timestamp": 1576797365612}, "reference-count": 28, "publisher": "MedCrave Group, LLC", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["GHOA"], "DOI": "10.15406/ghoa.2014.01.00006", "type": "journal-article", "created": {"date-parts": [[2014, 9, 17]], "date-time": "2014-09-17T05:42:50Z", "timestamp": 1410932570000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Stem Cell Therapy in the Treatment of Inflammatory Bowel Disease"], "prefix": "10.15406", "author": [{"given": "Nasadyuk", "family": "CM", "sequence": "first", "affiliation": []}], "member": "6139", "published-online": {"date-parts": [[2014, 5, 21]]}, "container-title": ["Gastroenterology & Hepatology: Open Access"], "link": [{"URL": "http://medcraveonline.com/GHOA/GHOA-01-00006.php", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T10:40:14Z", "timestamp": 1574764814000}, "score": 19.212053, "issued": {"date-parts": [[2014, 5, 21]]}, "references-count": 28, "URL": "http://dx.doi.org/10.15406/ghoa.2014.01.00006", "ISSN": ["2373-6372"], "issn-type": [{"value": "2373-6372", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:14:56Z", "timestamp": 1575530096087}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "1", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1990, 1, 1]]}, "DOI": "10.1182/blood.v75.1.317.bloodjournal751317", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T21:20:13Z", "timestamp": 1570915213000}, "page": "317-318", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML [letter]"], "prefix": "10.1182", "volume": "75", "author": [{"given": "GJ", "family": "Morgan", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Wiedemann", "sequence": "additional", "affiliation": []}, {"given": "LC", "family": "Chan", "sequence": "additional", "affiliation": []}, {"given": "CM", "family": "Price", "sequence": "additional", "affiliation": []}, {"given": "EJ", "family": "Kanfer", "sequence": "additional", "affiliation": []}, {"given": "DA", "family": "Galton", "sequence": "additional", "affiliation": []}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/75/1/317/218765/317.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/75/1/317/218765/317.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T00:01:38Z", "timestamp": 1574208098000}, "score": 18.914154, "issued": {"date-parts": [[1990, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1182/blood.v75.1.317.bloodjournal751317", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:24:42Z", "timestamp": 1575530682145}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "1", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1990, 1, 1]]}, "DOI": "10.1182/blood.v75.1.317.317", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T19:24:04Z", "timestamp": 1570994644000}, "page": "317-318", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML [letter]"], "prefix": "10.1182", "volume": "75", "author": [{"given": "GJ", "family": "Morgan", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Wiedemann", "sequence": "additional", "affiliation": []}, {"given": "LC", "family": "Chan", "sequence": "additional", "affiliation": []}, {"given": "CM", "family": "Price", "sequence": "additional", "affiliation": []}, {"given": "EJ", "family": "Kanfer", "sequence": "additional", "affiliation": []}, {"given": "DA", "family": "Galton", "sequence": "additional", "affiliation": []}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/75/1/317/601863/317.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/75/1/317/601863/317.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:39:00Z", "timestamp": 1574217540000}, "score": 18.914154, "issued": {"date-parts": [[1990, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1182/blood.v75.1.317.317", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T01:57:18Z", "timestamp": 1575251838348}, "reference-count": 69, "publisher": "Elsevier BV", "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Fluid Phase Equilibria"], "published-print": {"date-parts": [[2013, 10]]}, "DOI": "10.1016/j.fluid.2013.07.014", "type": "journal-article", "created": {"date-parts": [[2013, 7, 17]], "date-time": "2013-07-17T20:32:58Z", "timestamp": 1374093178000}, "page": "46-55", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Cross-diffusion in a colloid\u2013polymer aqueous system"], "prefix": "10.1016", "volume": "356", "author": [{"given": "Michele S.", "family": "McAfee", "sequence": "first", "affiliation": []}, {"given": "Onofrio", "family": "Annunziata", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Fluid Phase Equilibria"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0378381213003531?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0378381213003531?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 14]], "date-time": "2018-10-14T13:55:54Z", "timestamp": 1539525354000}, "score": 18.886837, "issued": {"date-parts": [[2013, 10]]}, "references-count": 69, "alternative-id": ["S0378381213003531"], "URL": "http://dx.doi.org/10.1016/j.fluid.2013.07.014", "ISSN": ["0378-3812"], "issn-type": [{"value": "0378-3812", "type": "print"}], "subject": ["Physical and Theoretical Chemistry", "General Physics and Astronomy", "General Chemical Engineering"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Cross-diffusion in a colloid\u2013polymer aqueous system", "name": "articletitle", "label": "Article Title"}, {"value": "Fluid Phase Equilibria", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.fluid.2013.07.014", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2013 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:59:30Z", "timestamp": 1574099970944}, "reference-count": 142, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 11, 1]], "date-time": "1996-11-01T00:00:00Z", "timestamp": 846806400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Critical Reviews in Oncology/Hematology"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.1016/1040-8428(96)00214-4", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T17:26:50Z", "timestamp": 1027618010000}, "page": "165-184", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Malignant tumors in patients with HIV infection"], "prefix": "10.1016", "volume": "24", "author": [{"given": "Umberto", "family": "Tirelli", "sequence": "first", "affiliation": []}, {"given": "Domenico", "family": "Errante", "sequence": "additional", "affiliation": []}, {"given": "Antonino", "family": "Carbone", "sequence": "additional", "affiliation": []}, {"given": "Annunziata", "family": "Gloghini", "sequence": "additional", "affiliation": []}, {"given": "Emanuela", "family": "Vaccher", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Critical Reviews in Oncology/Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:1040842896002144?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:1040842896002144?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 24]], "date-time": "2019-04-24T22:57:30Z", "timestamp": 1556146650000}, "score": 18.691736, "issued": {"date-parts": [[1996, 11]]}, "references-count": 142, "journal-issue": {"published-print": {"date-parts": [[1996, 11]]}, "issue": "3"}, "alternative-id": ["1040842896002144"], "URL": "http://dx.doi.org/10.1016/1040-8428(96)00214-4", "ISSN": ["1040-8428"], "issn-type": [{"value": "1040-8428", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}